Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NO-1886 (ibrolipim), a lipoprotein lipase activator, increases the expression of uncoupling protein 3 in skeletal muscle and suppresses fat accumulation in high-fat diet-induced obesity in rats.
Kusunoki M, Tsutsumi K, Iwata K, Yin W, Nakamura T, Ogawa H, Nomura T, Mizutani K, Futenma A, Utsumi K, Miyata T. Kusunoki M, et al. Among authors: miyata t. Metabolism. 2005 Dec;54(12):1587-92. doi: 10.1016/j.metabol.2005.06.005. Metabolism. 2005. PMID: 16311090
Relationship between serum concentrations of saturated fatty acids and unsaturated fatty acids and the homeostasis model insulin resistance index in Japanese patients with type 2 diabetes mellitus.
Kusunoki M, Tsutsumi K, Nakayama M, Kurokawa T, Nakamura T, Ogawa H, Fukuzawa Y, Morishita M, Koide T, Miyata T. Kusunoki M, et al. Among authors: miyata t. J Med Invest. 2007 Aug;54(3-4):243-7. doi: 10.2152/jmi.54.243. J Med Invest. 2007. PMID: 17878672 Free article.
Effects of Concomitant Administration of a Dipeptidyl Peptidase-4 Inhibitor in Japanese Patients with Type 2 Diabetes Showing Relatively Good Glycemic Control Under Treatment with a Sodium Glucose Co-Transporter 2 Inhibitor.
Kusunoki M, Natsume Y, Miyata T, Tsutsumi K, Oshida Y. Kusunoki M, et al. Among authors: miyata t. Drug Res (Stuttg). 2018 Dec;68(12):704-709. doi: 10.1055/a-0585-0145. Epub 2018 Jul 2. Drug Res (Stuttg). 2018. PMID: 29966149 Clinical Trial.
Effects of Additional Administration of a Selective Inhibitor of Sodium Glucose co-transporter-2 Inhibitor on the Glycemic Control in Japanese Type 2 Diabetes Mellitus Patients Receiving Treatment with a Dipeptidyl Peptidase-4 Inhibitor.
Kusunoki M, Sato D, Sakazaki T, Miyata T, Tsutsumi K, Oshida Y. Kusunoki M, et al. Among authors: miyata t. Drug Res (Stuttg). 2020 Apr;70(4):131-136. doi: 10.1055/a-1070-8783. Epub 2020 Mar 12. Drug Res (Stuttg). 2020. PMID: 32164029 Clinical Trial.
2,226 results